secwatch.observer — SEC 8-K summary
======================================

Issuer:     INCYTE CORP (INCY)
CIK:        0000879169
Form:       8-K
Filed at:   2026-08-31T20:29:25+00:00
Accession:  0000879169-26-000058
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Incyte signs CMS Medicaid pricing deal for Jakafi, avoids GUARD/GLOBE mandates
------------------------------------------------------------------------------

- Agreement with CMS enables state Medicaid access to Jakafi and Jakafi XR at prices aligned with a group of advanced industrialized nations.
- Company expects to be exempt from proposed CMS GUARD and GLOBE pricing models under the agreement.
- Incyte states the deal will not affect its 2026 financial guidance or have a material impact on its future financial outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879169/000087916926000058/0000879169-26-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879169/000087916926000058/incy-20260831.htm
  HTML page:      https://secwatch.observer/filing/0000879169-26-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer